Pulmonx (LUNG) Amortizatization of Intangibles (2019 - 2025)
Pulmonx (LUNG) reported Amortizatization of Intangibles of $465000.0 for Q3 2025, up 55.0% year-over-year from $300000.0 in Q3 2024, and up 13.69% quarter-over-quarter from $409000.0 in Q2 2025.
Pulmonx (LUNG) Amortizatization of Intangibles (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has 7 years of Amortizatization of Intangibles data on file, last reported at $465000.0 in Q3 2025.
- Amortizatization of Intangibles for Q3 2025 came in at $465000.0, up 55.0% year-over-year; the trailing twelve-month figure through Sep 2025 was $1.4 million (down 59.61% YoY), and the FY2024 annual result was $1.8 million, down 31.35% from the prior year.
- Amortizatization of Intangibles improved to $465000.0 in Q3 2025 per LUNG's latest filing, from $409000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $2.0 million in Q4 2023 and troughed at -$1.7 million in Q4 2022.
- A 5-year average of $302894.7 and a median of $465000.0 in 2025 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2021 and 2022: Amortizatization of Intangibles soared 424.16% in 2021, then tumbled 7422.73% in 2022.
- A 5-year view of Amortizatization of Intangibles shows it stood at -$22000.0 in 2021, then plunged by 7422.73% to -$1.7 million in 2022, then jumped by 220.06% to $2.0 million in 2023, then tumbled by 83.24% to $333000.0 in 2024, then soared by 39.64% to $465000.0 in 2025.
- Business Quant data shows LUNG's Amortizatization of Intangibles at $465000.0 in Q3 2025, $409000.0 in Q2 2025, and $206000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 422.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 180.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 6.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 75.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Pulmonx | 54.38 Mn | -15.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 465,000.00 |
| Sep 30, 2025 | 465,000.00 |
| Jun 30, 2025 | 409,000.00 |
| Jun 30, 2025 | 409,000.00 |
| Mar 31, 2025 | 206,000.00 |
| Mar 31, 2025 | 206,000.00 |
| Dec 31, 2024 | 333,000.00 |
| Dec 31, 2024 | 333,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 510,000.00 |
| Jun 30, 2024 | 510,000.00 |
| Mar 31, 2024 | 701,000.00 |
| Mar 31, 2024 | 701,000.00 |
| Dec 31, 2023 | 1.99 Mn |
| Dec 31, 2023 | 1.99 Mn |
| Sep 30, 2023 | -625,000.00 |
| Sep 30, 2023 | -625,000.00 |
| Jun 30, 2023 | 1.12 Mn |
| Jun 30, 2023 | 1.12 Mn |